Evaluation of fibrin-based gene-activated matrices for BMP2/7 plasmid codelivery in a rat nonunion model

International Orthopaedics

Volumn 38, Issue 12, 2014, Pages 2607-2613

  Kaipel, Martin ^a,b   Schützenberger, Sebastian ^b   Hofmann, Anna T ^b   Ferguson, James ^b   Nau, Thomas ^b   Redl, Heinz ^b   Feichtinger, Georg A ^b  

^a KRANKENHAUS DER BARMHERZIGEN BRÜDER   (Austria)

^b LUDWIG BOLTZMANN INSTITUTE FOR LUNG VASCULAR RESEARCH   (Austria)

Author keywords

BMP2 7 plasmids; Cationic polymers; Fibrin; Gene activated matrix; Gene therapy; Nonunion

Indexed keywords

FIBRIN; FIBRIN GLUE; OSTEOGENIC PROTEIN 1; POLYMER; RECOMBINANT BONE MORPHOGENETIC PROTEIN 2; BMP2 PROTEIN, RAT; BONE MORPHOGENETIC PROTEIN; BONE MORPHOGENETIC PROTEIN 2; RECOMBINANT HUMAN BONE MORPHOGENETIC PROTEIN-2; RECOMBINANT PROTEIN; TRANSFORMING GROWTH FACTOR BETA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BONE DENSITY; BONE MASS; CONTROLLED STUDY; GENE ACTIVATION; GENE THERAPY; GENETIC TRANSFECTION; MALE; NONHUMAN; PLASMID; PSEUDARTHROSIS; RAT; ANIMAL; BONE DEVELOPMENT; BONE REGENERATION; DISEASE MODEL; DRUG EFFECTS; GENE TRANSFER; GENETICS; PHYSIOLOGY; PROCEDURES; SPRAGUE DAWLEY RAT; TISSUE ENGINEERING;

ANIMALS; BONE MORPHOGENETIC PROTEIN 2; BONE MORPHOGENETIC PROTEINS; BONE REGENERATION; DISEASE MODELS, ANIMAL; FIBRIN; GENE TRANSFER TECHNIQUES; GENETIC THERAPY; MALE; OSTEOGENESIS; PLASMIDS; RATS, SPRAGUE-DAWLEY; RECOMBINANT PROTEINS; TISSUE ENGINEERING; TRANSFORMING GROWTH FACTOR BETA;

EID: 84911460485     PISSN: 03412695     EISSN: 14325195     Source Type: Journal    
DOI: 10.1007/s00264-014-2499-3     Document Type: Article

References (33)

1. Vukicevic S, Oppermann H, Verbanac D, Jankolija M, Popek I, Curak J, Brkljacic J, Pauk M, Erjavec I, Francetic I, Dumic-Cule I, Jelic M, Durdevic D, Vlahovic T, Novak R, Kufner V, Bordukalo Niksic T, Kozlovic M, Banic Tomisic Z, Bubic-Spoljar J, Bastalic I, Vikic-Topic S, Peric M, Pecina M, Grgurevic L (2014) The clinical use of bone morphogenetic proteins revisited: a novel biocompatible carrier device OSTEOGROW for bone healing. Int Orthop 38(3):635–647. doi:10.1007/s00264-013-2201-1
2. Lissenberg-Thunnissen SN, de Gorter DJ, Sier CF, Schipper IB (2011) Use and efficacy of bone morphogenetic proteins in fracture healing. Int Orthop 35(9):1271–1280. doi:10.1007/s00264-011-1301-z
3. Evans C (2011) Gene therapy for the regeneration of bone. Injury 42(6):599–604. doi:10.1016/j.injury.2011.03.032
4. Fischer J, Kolk A, Wolfart S, Pautke C, Warnke PH, Plank C, Smeets R (2011) Future of local bone regeneration–protein versus gene therapy. J Craniomaxillofac Surg 39(1):54–64. doi:10.1016/j.jcms.2010.03.016
5. Ivkovic A, Marijanovic I, Hudetz D, Porter RM, Pecina M, Evans CH (2011) Regenerative medicine and tissue engineering in orthopaedic surgery. Front Biosci (Elite Ed) 3:923–944
6. Borovecki F, Pecina-Slaus N, Vukicevic S (2007) Biological mechanisms of bone and cartilage remodelling–genomic perspective. Int Orthop 31(6):799–805. doi:10.1007/s00264-007-0408-8
7. Zhu W, Rawlins BA, Boachie-Adjei O, Myers ER, Arimizu J, Choi E, Lieberman JR, Crystal RG, Hidaka C (2004) Combined bone morphogenetic protein-2 and -7 gene transfer enhances osteoblastic differentiation and spine fusion in a rodent model. J Bone Miner Res 19(12):2021–2032. doi:10.1359/JBMR.040821
8. Kawai M, Bessho K, Maruyama H, Miyazaki J, Yamamoto T (2006) Simultaneous gene transfer of bone morphogenetic protein (BMP) -2 and BMP-7 by in vivo electroporation induces rapid bone formation and BMP-4 expression. BMC Musculoskelet Disord 7:62. doi:10.1186/1471-2474-7-62
9. Kawai M, Maruyama H, Bessho K, Yamamoto H, Miyazaki J, Yamamoto T (2009) Simple strategy for bone regeneration with a BMP-2/7 gene expression cassette vector. Biochem Biophys Res Commun 390(3):1012–1017. doi:10.1016/j.bbrc.2009.10.099
10. Evans CH (2010) Gene therapy for bone healing. Expert Rev Mol Med 12:e18. doi:10.1017/S1462399410001493
11. Ivkovic A, Pascher A, Hudetz D, Maticic D, Jelic M, Dickinson S, Loparic M, Haspl M, Windhager R, Pecina M (2010) Articular cartilage repair by genetically modified bone marrow aspirate in sheep. Gene Ther 17(6):779–789. doi:10.1038/gt.2010.16
12. Evans CH (2012) Gene delivery to bone. Adv Drug Deliv Rev 64(12):1331–1340. doi:10.1016/j.addr.2012.03.013
13. Pelled G, Ben-Arav A, Hock C, Reynolds DG, Yazici C, Zilberman Y, Gazit Z, Awad H, Gazit D, Schwarz EM (2010) Direct gene therapy for bone regeneration: gene delivery, animal models, and outcome measures. Tissue Eng B Rev 16(1):13–20. doi:10.1089/ten.teb.2009.0156
14. Pannier AK, Shea LD (2004) Controlled release systems for DNA delivery. Mol Ther 10(1):19–26. doi:10.1016/j.ymthe.2004.03.020
15. Wiethoff CM, Middaugh CR (2003) Barriers to nonviral gene delivery. J Pharm Sci 92(2):203–217. doi:10.1002/jps.10286
16. Zauner W, Brunner S, Buschle M, Ogris M, Wagner E (1999) Differential behaviour of lipid based and polycation based gene transfer systems in transfecting primary human fibroblasts: a potential role of polylysine in nuclear transport. Biochim Biophys Acta 1428(1):57–67
17. Ma B, Zhang S, Jiang H, Zhao B, Lv H (2007) Lipoplex morphologies and their influences on transfection efficiency in gene delivery. J Control Release 123(3):184–194. doi:10.1016/j.jconrel.2007.08.022
18. Dass CR (2004) Lipoplex-mediated delivery of nucleic acids: factors affecting in vivo transfection. J Mol Med 82(9):579–591. doi:10.1007/s00109-004-0558-8
19. Park J, Lutz R, Felszeghy E, Wiltfang J, Nkenke E, Neukam FW, Schlegel KA (2007) The effect on bone regeneration of a liposomal vector to deliver BMP-2 gene to bone grafts in peri-implant bone defects. Biomaterials 28(17):2772–2782. doi:10.1016/j.biomaterials.2007.02.009
20. Lutz R, Park J, Felszeghy E, Wiltfang J, Nkenke E, Schlegel KA (2008) Bone regeneration after topical BMP-2-gene delivery in circumferential peri-implant bone defects. Clin Oral Implants Res 19(6):590–599. doi:10.1111/j.1600-0501.2007.01526.x
21. des Rieux A, Shikanov A, Shea LD (2009) Fibrin hydrogels for nonviral vector delivery in vitro. J Control Release 136(2):148–154. doi:10.1016/j.jconrel.2009.02.004
22. Michlits W, Mittermayr R, Schafer R, Redl H, Aharinejad S (2007) Fibrin-embedded administration of VEGF plasmid enhances skin flap survival. Wound Repair Regen 15(3):360–367. doi:10.1111/j.1524-475X.2007.00238.x
23. Feichtinger GA, Hofmann AT, Wassermann K, Zimmermann A, van Griensven M, Redl H (2014) Constitutive and inducible coexpression systems for nonviral osteoinductive gene therapy. Eur Cell Mater 27:166–184, discussion 184
24. Schmidhammer R, Zandieh S, Mittermayr R, Pelinka LE, Leixnering M, Hopf R, Kroepfl A, Redl H (2006) Assessment of bone union/nonunion in an experimental model using microcomputed technology. J Trauma 61(1):199–205. doi:10.1097/01.ta.0000195987.57939.7e
25. Zaliauskiene L, Bernadisiute U, Vareikis A, Makuska R, Volungeviciene I, Petuskaite A, Riauba L, Lagunavicius A, Zigmantas S (2010) Efficient gene transfection using novel cationic polymers poly(hydroxyalkylene imines). Bioconjug Chem 21(9):1602–1611. doi:10.1021/bc900535k
26. Weber B (1976) Pseudarthrosis. Grune and Stratton, New York
27. Tierney EG, Duffy GP, Hibbitts AJ, Cryan SA, O’Brien FJ (2012) The development of nonviral gene-activated matrices for bone regeneration using polyethyleneimine (PEI) and collagen-based scaffolds. J Control Release 158(2):304–311. doi:10.1016/j.jconrel.2011.11.026
28. Tierney EG, Duffy GP, Cryan SA, Curtin CM, O’Brien FJ (2013) nonviral gene-activated matrices: next generation constructs for bone repair. Organogenesis 9(1):22–28. doi:10.4161/org.24329
29. Kawakami S, Higuchi Y, Hashida M (2008) Nonviral approaches for targeted delivery of plasmid DNA and oligonucleotide. J Pharm Sci 97(2):726–745. doi:10.1002/jps.21024
30. Sheyn D, Kimelman-Bleich N, Pelled G, Zilberman Y, Gazit D, Gazit Z (2008) Ultrasound-based nonviral gene delivery induces bone formation in vivo. Gene Ther 15(4):257–266. doi:10.1038/sj.gt.3303070
31. Feichtinger GA, Hofmann AT, Slezak P, Schuetzenberger S, Kaipel M, Schwartz E, Neef A, Nomikou N, Nau T, van Griensven M, McHale AP, Redl H (2014) Sonoporation increases therapeutic efficacy of inducible and constitutive BMP2/7 in vivo gene delivery. Hum Gene Ther Methods 25(1):57–71. doi:10.1089/hgtb.2013.113
32. Kaipel M, Schutzenberger S, Schultz A, Ferguson J, Slezak P, Morton TJ, Van Griensven M, Redl H (2012) BMP-2 but not VEGF or PDGF in fibrin matrix supports bone healing in a delayed-union rat model. J Orthop Res 30(10):1563–1569. doi:10.1002/jor.22132
33. Nomikou N, Feichtinger GA, Redl H, McHale AP (2013) Ultrasound-mediated gene transfer (sonoporation) in fibrin-based matrices: potential for use in tissue regeneration. J Tissue Eng Regen Med. doi:10.1002/term.1730